Diagnostics
Total Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
1,877
NCT02040441
Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
Phase: Phase 2/3
Role: Collaborator
Start: Mar 31, 2014
Completion: Nov 30, 2018
NCT02398630
"Magnetic Resonance Imaging Hysterosalpingography for the Integral Evaluation of the Infertile Patient."
Phase: N/A
Role: Lead Sponsor
Start: Sep 30, 2014
Completion: Not specified
NCT06954090
Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study
Phase: Phase 4
Start: Jun 1, 2025
Completion: Dec 31, 2026
Loading map...